Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,328 GBX | -1.82% |
|
-0.56% | +16.30% |
27/06 | US FDA declines to approve Merck-Daiichi's 'guided missile' cancer drug | RE |
26/06 | European Equities Close Lower in Wednesday Trading | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.30% | 246B | |
+55.95% | 811B | |
+43.62% | 640B | |
-6.98% | 353B | |
+19.08% | 333B | |
+9.05% | 302B | |
+2.41% | 225B | |
+12.47% | 218B | |
+8.91% | 168B | |
-3.44% | 155B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- ASTRAZENECA : JP Morgan remains its Buy rating